Explorer
Covaxin demonstrates protection against deadly new variants
A study published by Clinical Infectious Diseases found that vaccination with Covaxin produced neutralising titres against all key emerging variants tested including B1617 and B117, first identified in India and the UK, respectively.
A modest reduction in neutralization by a factor of 1.95 was observed against B1617 variant compared to vaccine variant.
India
Breaking News: UGC NET Re-Exam Row Grows as Rahul Gandhi Questions NTA Accountability and Student Burden
Breaking News: Vande Mataram Row Escalates as BJP Demands Sonia Gandhi’s Apology, Police Complaints Filed
Breaking News: Lakhisarai Ashok Dham Stampede Claims 8 Lives, Raises Fresh Questions Over Crowd Control
Breaking News: Lakhisarai Ashok Dham Stampede Death Toll Rises to 8 Amid Crowd Safety Questions
Breaking: Sawan Monday Tragedy: Bihar Temple Stampede and Bengal Hotel Fire Leave 11 Dead
View More
Trending News




















